• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»BD Incada

Why BD’s Wellstar partnership could reshape medication delivery inside hospitals

By Pallavi Madhiraju on May 9, 2026   Medical Devices & Diagnostics  

Why BD’s Wellstar partnership could reshape medication delivery inside hospitals

Hospitals need safer medication delivery, not more disconnected tech. BD and Wellstar are testing whether AI can close that workflow gap.

Recent Posts

  • Lumenis strengthens FoLix, ULTRApulse Alpha and Stellar M22 case with ASLMS data
  • How Zifo’s AI authoring platform could reshape clinical and CMC documentation
  • INOVIO’s ASCO and ASGCT updates may sharpen scrutiny of its DNA medicine strategy
  • Pharma has a Hispanic engagement problem. Relevant+ thinks Healthy Vibras can fix it
  • What Soligenix’s Q1 update reveals about biotech risk after a failed confirmatory trial
  • ACROBiosystems makes HEK293 functional cell lines easier to use in global R&D workflows
  • Why PureHealth Research’s berberine GLP-1 supplement push enters a crowded evidence debate
  • Inhibrx’s HexAgon study may test whether smarter OX40 design can beat old failures
  • Why Kelun-Biotech’s sac-TMT review could reshape China’s lung cancer ADC market
  • Can KUBTEC Scientific lower the barrier to image-guided radiotherapy in cancer research?
  • Why Argenx’s broader Vyvgart label changes the treatment equation in generalized myasthenia gravis
  • Why ALX Oncology’s ASPEN-09 readout may matter beyond one HER2 breast cancer study
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes